Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? Equity (Details)

v3.26.1
Stockholders’ Equity (Details)
 12 Months Ended
Nov. 28, 2025
shares
Jun. 20, 2025
USD ($)
$ / shares
shares
May 31, 2025
USD ($)
$ / shares
shares
May 06, 2025
shares
Nov. 26, 2024
Sep. 30, 2024
USD ($)
$ / shares
shares
Jan. 02, 2024
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Jan. 28, 2026
shares
Sep. 03, 2025
shares
Sep. 26, 2024
$ / shares
shares
Stockholders’ Equity [Line Items]                        
Number of aggregate authorized shares               105,000,000        
Common stock, shares authorized               100,000,000 100,000,000      
Purchase price per share (in Dollars per share) | $ / shares               $ 0.0001 $ 0.0001      
Preferred stock, shares authorized               5,000,000 5,000,000      
Preferred stock, par value (in Dollars per share) | $ / shares               $ 0.0001 $ 0.0001      
Common stock shares issued               23,091,062 1,394,263      
Common stock shares outstanding               23,091,062 1,394,263      
Common stock, voting rights               one        
Aggregate gross proceeds (in Dollars) | $     $ 1,300,000         $ 2,078,348      
Net proceeds after deducting placement (in Dollars) | $           $ 4,500,000            
Percentage of commission         3.00%              
Common stock (in Dollars) | $               2,309 139      
Issuance of common stock from the exercise of pre-funded warrants     1                  
Beneficial ownership limitation effective days     61 days                  
Aggregate net proceeds (in Dollars) | $     $ 4,200,000                  
Net proceeds public offering (in Dollars) | $               55,424,354      
Loss on warrant liability (in Dollars) | $               416,619      
Fair value of placement agent warrants (in Dollars) | $               $ 3,842,857      
Pre-Funded Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Shares issued price per (in Dollars per share) | $ / shares     $ 0.001                  
Warrants exercised shares                 348,513      
Sell aggregate share       3,094,284                
Issued common stock warrants purchase       3,571,428                
Issuance of common stock from the exercise of pre-funded warrants     477,144                  
Series A Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants term               5 years        
Series B Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants term               18 months        
September 2024 Pre Funded Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants purchase               871,000 871,000      
May 2025 Pre-Funded Warrant [Member]                        
Stockholders’ Equity [Line Items]                        
Shares issued price per (in Dollars per share) | $ / shares     $ 1.399                  
Series C Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants term     5 years                  
Issued common stock warrants purchase       3,571,428                
Issuance of common stock from the exercise of pre-funded warrants     1                  
Exercise price per share (in Dollars per share) | $ / shares     $ 1.4                  
exercisable upon issuance     5 years                  
Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Issued common stock warrants purchase       3,571,428                
Series D warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Aggregate gross proceeds (in Dollars) | $     $ 6,300,000                  
Issued common stock warrants purchase       3,571,428                
Exercise price per share (in Dollars per share) | $ / shares     $ 1.4                  
exercisable upon issuance     18 months                  
Issuance of common stock     914,286                  
May 2025 Placement Agent Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock shares issued     250,000                  
Shares issued price per (in Dollars per share) | $ / shares     $ 1.75                  
Issued common stock warrants purchase               250,000        
December 2025 Pre-Funded Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants exercise price (in Dollars per share) | $ / shares               $ 0.001        
Shares issued price per (in Dollars per share) | $ / shares               $ 0.749        
December 2025 Placement Agent Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Issued common stock warrants purchase               4,000,000        
Private Investment in Public Equity (PIPE) Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Own beneficially percentage     4.99%     4.99%            
Private Investment in Public Equity (PIPE) Warrants [Member] | Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Own beneficially percentage     9.99%     9.99%            
December 2025 Public Offering [Member]                        
Stockholders’ Equity [Line Items]                        
Own beneficially percentage               4.99%        
December 2025 Public Offering [Member] | Pre-Funded Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Own beneficially percentage               9.99%        
2021 Stock Incentive Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Stock option outstanding               61,250        
2023 Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Number of shares available for issuance               389,628        
Unused shares               28,389        
Common stock outstanding shares percentage               3.00%        
Common stock available for issuance               2,014,221        
September 2024 Private Placement [Member]                        
Stockholders’ Equity [Line Items]                        
Aggregate gross proceeds (in Dollars) | $           $ 4,500,000            
September 2024 Private Placement [Member] | Series A Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants purchase                       1,219,513
Warrants exercise price (in Dollars per share) | $ / shares                       $ 3.85
September 2024 Private Placement [Member] | Series B Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants purchase                       1,219,513
Warrants exercise price (in Dollars per share) | $ / shares                       $ 3.85
September 2024 Private Placement [Member] | Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Shares issued price per (in Dollars per share) | $ / shares           $ 4.099            
Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock shares issued               23,091,062 1,394,263      
Common stock shares outstanding               23,091,062 1,394,263      
Common Stock [Member] | Placement Agent Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants purchase           85,366            
Warrants exercise price (in Dollars per share) | $ / shares           $ 5.125            
Warrants term           5 years            
Common Stock [Member] | May 2025 Pre-Funded Warrant [Member]                        
Stockholders’ Equity [Line Items]                        
Issued common stock warrants purchase       477,144                
Common Stock [Member] | Ownership Limitation [Member] | Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Own beneficially percentage     9.99%     9.99%            
Common Stock [Member] | December 2025 Public Offering [Member]                        
Stockholders’ Equity [Line Items]                        
Own beneficially percentage               9.99%        
Common Stock [Member] | 2023 Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock shares issued               1,624,593        
Common stock shares outstanding               1,624,593        
Common Stock [Member] | September 2024 Pre Funded Warrants [Member] | Pre-Funded Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants purchase                       1,219,513
Warrants exercise price (in Dollars per share) | $ / shares                       $ 0.001
ATM Agreement [Member]                        
Stockholders’ Equity [Line Items]                        
Shares issued price per (in Dollars per share) | $ / shares               $ 2.68        
Gross proceeds (in Dollars) | $               $ 2,078,348        
ATM Agreement [Member] | Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock (in Dollars) | $                 $ 2,076,000      
Sell aggregate share               801,278        
At The Market Agreement with H.C. Wainwright [Member]                        
Stockholders’ Equity [Line Items]                        
Shares issued price per (in Dollars per share) | $ / shares   $ 4,227,000                    
Gross proceeds (in Dollars) | $   $ 2,151,000                    
At The Market Agreement with H.C. Wainwright [Member] | Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock shares issued   2,076,000                    
Securities Purchase Agreements [Member] | May 2025 Pre-Funded Warrant [Member]                        
Stockholders’ Equity [Line Items]                        
Issued common stock warrants purchase       477,144                
Restricted Stock Units [Member]                        
Stockholders’ Equity [Line Items]                        
Restricted common stock shares issued               0 4,168      
Stock-based compensation expense (in Dollars) | $               $ 0 $ 117,000      
Restricted Stock Units [Member] | 2023 Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Number of shares available for issuance               125,000        
December 2025 Public Offering [Member]                        
Stockholders’ Equity [Line Items]                        
Placement agent warrant issuance costs (in Dollars) | $               $ 3,426,238        
Minimum [Member]                        
Stockholders’ Equity [Line Items]                        
Reverse stock split             1          
Minimum [Member] | 2023 Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock available for issuance                     1,750,000  
Minimum [Member] | Subsequent Event [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock, shares authorized                   100,000,000    
Minimum [Member] | Subsequent Event [Member] | 2023 Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Number of shares authorized                   11,985,779    
Maximum [Member]                        
Stockholders’ Equity [Line Items]                        
Reverse stock split             20          
Maximum [Member] | 2023 Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock available for issuance                     2,014,221  
Maximum [Member] | Subsequent Event [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock, shares authorized                   500,000,000    
Maximum [Member] | Subsequent Event [Member] | 2023 Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Number of shares authorized                   14,000,000    
IPO [Member]                        
Stockholders’ Equity [Line Items]                        
Shares issued price per (in Dollars per share) | $ / shares     $ 1.4         $ 0.75        
December 2025 Public Offering [Member]                        
Stockholders’ Equity [Line Items]                        
Public offering shares 14,846,665                      
Net proceeds public offering (in Dollars) | $               $ 54,900,000        
Common stock exercise price (in Dollars per share) | $ / shares               $ 0.9375        
December 2025 Public Offering [Member] | Pre-Funded Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Beneficial ownership limitation effective days               61 days        
December 2025 Pre-Funded Warrants [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants purchase 65,153,335                      
December 2025 Pre-Funded Warrant Shares [Member]                        
Stockholders’ Equity [Line Items]                        
Warrants purchase 65,153,335